Nxera Pharma Co., Ltd.
4565.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥5 | -¥7 | ¥1 | ¥0 |
| Dep. & Amort. | ¥4 | ¥2 | ¥1 | ¥1 |
| Deferred Tax | ¥0 | -¥1 | ¥0 | ¥3 |
| Stock-Based Comp. | ¥1 | ¥1 | ¥1 | ¥1 |
| Change in WC | -¥7 | ¥2 | ¥5 | -¥2 |
| Other Non-Cash | -¥1 | -¥2 | ¥2 | ¥4 |
| Operating Cash Flow | -¥8 | -¥5 | ¥10 | ¥7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥1 | -¥1 | -¥0 | -¥0 |
| Net Acquisitions | ¥0 | -¥63 | ¥0 | ¥0 |
| Inv. Purchases | ¥0 | ¥0 | -¥0 | -¥0 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥1 | ¥0 |
| Other Inv. Act. | -¥5 | ¥0 | ¥0 | ¥0 |
| Investing Cash Flow | -¥5 | -¥64 | ¥1 | ¥0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥7 | ¥70 | ¥0 | ¥11 |
| Stock Issued | ¥0 | ¥10 | ¥0 | ¥1 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | -¥0 | -¥32 | -¥5 | -¥0 |
| Financing Cash Flow | -¥7 | ¥48 | -¥5 | ¥11 |
| Forex Effect | ¥3 | ¥3 | ¥0 | ¥2 |
| Net Chg. in Cash | -¥17 | -¥17 | ¥6 | ¥20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥49 | ¥67 | ¥60 | ¥40 |
| End Cash | ¥32 | ¥49 | ¥67 | ¥60 |
| Free Cash Flow | -¥8 | -¥6 | ¥10 | ¥7 |